FDA.reportPublic FDA data

NDC 76299-321-01 - Stendra

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
76299-321
Requested NDC
76299-321-01
Package NDCs from labels
76299-321-01, 76299-321-96, 76299-321-85, 76299-321-88
Manufacturer
Mist Pharmaceuticals, LLC
Effective date
2021-05-24
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Stendra - Mist Pharmaceuticals, LLCMist Pharmaceuticals, LLC2021-05-24HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
76299-321-852023-02-15These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-882023-02-15These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-962023-02-15These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-852023-01-30These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-882023-01-30These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-962023-01-30These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-852020-07-02These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-882020-07-02These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-962020-07-02These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-852020-01-31These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-882020-01-31These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012
76299-321-962020-01-31These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
76299-321-85EA - Each76299-321afabd2ea-ffbc-4328-acef-1ea2a234c3ce12017-08-11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 16 of 36 · 710 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
WALGREENS EXTRA STRENGTH SMOOTH ANTACIDCALCIUM CARBONATEWALGREENS CO.9a5631e8-4287-4368-bb56-3ce22a3680d82025-11-04WarningsExact identifier
unii: H0G9379FGK
up and up extra strength antacid 750 Assorted BerryANTACID TABLETSTarget Corporation46f11acf-a968-4fdd-8755-3eff0b9b67d02025-11-04WarningsExact identifier
unii: H0G9379FGK
up and up extra strength antacid 750 Assorted BerryANTACID TABLETSTarget Corporationb76441ad-f701-4d0d-b9a7-18ac466faa442025-11-04WarningsExact identifier
unii: H0G9379FGK
extra strength Tropical FruitANTACIDTarget Corporationb2c2fcb4-5a47-47eb-ae0e-6bc3713b161d2025-11-04WarningsExact identifier
unii: H0G9379FGK
ultra strength Assorted FruitCALCIUM CARBONATE ANTACIDTarget Corporationa0f2ac91-c425-4e6d-8dd6-224a5b85cd2e2025-11-04WarningsExact identifier
unii: H0G9379FGK
ultra strength antacid Peppermint FlavoredCALCIIUM CARBONATETarget Corporation55dc1614-8fc0-4f2c-abfc-b675173b4f072025-11-04WarningsExact identifier
unii: H0G9379FGK
ultra strength antacidANTACIDTarget Corporation2125e81b-23c6-4c5f-a6aa-829f8d3df71f2025-11-04WarningsExact identifier
unii: H0G9379FGK
up and up extra strength smooth dissolving antacid Assorted berryANTACID TABLETSTarget Corporatione78afe7b-a835-4fdb-9ef8-0499d1a83e6e2025-11-04WarningsExact identifier
unii: H0G9379FGK
up and up extra strength smooth dissolving antacid Assorted FruitCALCIUM CARBONATETarget corporationb97558c5-d836-42ae-bfa5-0f4c6bca7e4a2025-11-04WarningsExact identifier
unii: H0G9379FGK
Ultra Strength AntacidCALCIUM CARBONATE PEPPERMINTTARGET CORPORATION07aa98b3-699a-bf8d-e063-6294a90a2dee2025-11-04WarningsExact identifier
unii: H0G9379FGK
Extra Strength Antacid Calcium Carbonate,750 mgCALCIUM CARBONATETARGET CORPORATION07aa39bb-c409-ce4f-e063-6394a90a70692025-11-04WarningsExact identifier
unii: H0G9379FGK
Sorbitol-MannitolSORBITOL AND MANNITOLICU Medical Inc.5b44e248-4b7b-4777-954a-921c7b3099442025-10-30Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
Regular Strength AntacidCALCIUM CARBONATESAFEWAYce44254f-6e33-4cbd-a609-6a926376efaf2025-10-29WarningsExact identifier
unii: H0G9379FGK
Extra StrengthCALCIUM CARBONATEBETTER LIVING BRANDS, LLC9b311b76-1892-4b74-a07a-8b321436d4a02025-10-29WarningsExact identifier
unii: H0G9379FGK
Extra StrengthANTACID TABLETSSAFEWAYf91aa7da-8bdc-4fd2-a9de-fef21674e5152025-10-29WarningsExact identifier
unii: H0G9379FGK
Extra Strength SmoothCALCIUM CARBONATESAFEWAY4314ac58-03aa-479c-a711-4818cc3325312025-10-29WarningsExact identifier
unii: H0G9379FGK
Extra StrengthANTACID TABLETSSAFEWAY5bdb868d-016d-4175-9283-86c5b77bb26e2025-10-29WarningsExact identifier
unii: H0G9379FGK
Extra StrengthANTACID TABLETSSAFEWAY03853f03-081d-4a78-b383-66ac9754d46f2025-10-29WarningsExact identifier
unii: H0G9379FGK
Ultra StrengthCALCIUM CARBONATEBETTER LIVING BRANDS LLC3ff92c9a-987f-468e-9e18-1e3e171ede142025-10-29WarningsExact identifier
unii: H0G9379FGK
Ultra StrengthCALCIUM CARBONATEBETTER LIVING BRANDS LLC35b3d9d0-b04d-4f6d-b99d-435233803d4b2025-10-29WarningsExact identifier
unii: H0G9379FGK

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.